Results 1 to 10 of about 3,345,648 (379)

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. [PDF]

J Am Heart Assoc, 2018
Background Our objective was to determine patterns of antihypertensive agent use by stage of chronic kidney disease (CKD) and to evaluate the association between different classes of antihypertensive agents with nonrenal outcomes, especially in advanced ...
Ku E, McCulloch CE, Vittinghoff E, Lin F, Johansen KL.   +4 more
europepmc   +5 more sources

Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19. [PDF]

Cardiovasc Drugs Ther, 2022
The role of angiotensin receptor blockers (ARB), angiotensin-converting enzyme inhibitors (ACEi), or other antihypertensive agents in the case of Covid-19 remains controversial.
Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, Polard E, Burgun A, Treluyer JM, Neuraz A, AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium”.   +12 more
europepmc   +2 more sources

Systolic Blood Pressure Variability When Transitioning From Intravenous to Enteral Antihypertensive Agents in Patients With Hemorrhagic Strokes [PDF]

Frontiers in Neurology, 2022
Background/ObjectiveSystolic blood pressure variability (SBPV) in patients with intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH) is associated with an increased risk of acute kidney injury (AKI) and mortality. SBPV is a strong predictor of
Abdulrahman I. Alshaya, Abdulrahman I. Alshaya, Abdulrahman I. Alshaya, Meshari Alghamdi, Meshari Alghamdi, Meshari Alghamdi, Sumaya N. Almohareb, Sumaya N. Almohareb, Sumaya N. Almohareb, Omar A. Alshaya, Omar A. Alshaya, Omar A. Alshaya, Mohammed Aldhaeefi, Mohammed Aldhaeefi, Mohammed Aldhaeefi, Mohammed Aldhaeefi, Abdullah F. Alharthi, Sulaiman Almohaish, Sulaiman Almohaish   +18 more
doaj   +2 more sources

Antihypertensive agents: a long way to safe drug prescribing in children. [PDF]

Pediatr Nephrol, 2020
Recently updated clinical guidelines have highlighted the gaps in our understanding and management of pediatric hypertension. With increased recognition and diagnosis of pediatric hypertension, the use of antihypertensive agents is also likely to ...
Siddiqi N, Shatat IF.
europepmc   +2 more sources

Antihypertensive agents and arterial stiffness. [PDF]

J Thorac Dis, 2016
Carotid-femoral pulse wave velocity (cfPWV) is the goldstandard method to measure arterial stiffness (1), which has been shown to be an important predictor of cardiovascular events and death (1-3).
Gismondi RA, Oigman W, Neves MF.
europepmc   +5 more sources

Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis. [PDF]

Br J Clin Pharmacol, 2014
AIMS In response to safety concerns from two large randomized controlled trials, we investigated whether the use of telmisartan, an angiotensin receptor blocker (ARB), ARBs as a class and angiotensin-converting enzyme inhibitors (ACEIs) increase the risk
Dial S, Nessim SJ, Kezouh A, Benisty J, Suissa S.   +4 more
europepmc   +2 more sources

Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study. [PDF]

PLoS One, 2014
Background and Purpose Hypertension has been associated with Parkinson's disease (PD), but data on antihypertensive drugs and PD are inconclusive. We aim to evaluate antihypertensive drugs for an association with PD in hypertensive patients.
Lee YC, Lin CH, Wu RM, Lin JW, Chang CH, Lai MS.   +5 more
europepmc   +2 more sources

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [PDF]

Patient Preference and Adherence, 2019
Hamzah Bakouni,1,2 Lia Gentil,3 Helen-Maria Vasiliadis1–2,41Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada; 2Centre de recherche Charles-Le Moyne – Saguenay–Lac-Saint-Jean sur les ...
Bakouni H, Gentil L, Vasiliadis HM
doaj   +2 more sources

Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents [PDF]

International Journal of Hypertension
The lipid-based drug delivery system (LBDDS) is a well-established technique that is anticipated to bring about comprehensive transformations in the pharmaceutical field, impacting the management and administration of drugs, as well as treatment and ...
null Preeti, Sharda Sambhakar, Rohit Malik, Saurabh Bhatia, Ahmed Al Harrasi, Renu Saharan, Geeta Aggarwal, Suresh Kumar, Renu Sehrawat, Chanchal Rani   +9 more
doaj   +2 more sources

Effectiveness of antihypertensive agents in stage I/II hypertensive patients with ace (I/D) gene polymorphism

Journal of Medical and Scientific Research, 2023
Background: Angiotensin converting enzyme (ACE) is the key enzyme, regulates the blood pressure which is encoded by 21kb gene that consists of 26 exons and is located on chromosome 17, contains a polymorphism in the form of either Insertion (I) or ...
Bansal G, Chaithanya TM, Alam MA, Manchi RK   +3 more
doaj   +1 more source